Royalty Pharma logo

Royalty Pharma

RPRX | NASDAQ
Chart Builder DCF Calculator
$58.46
+$0.02 (+0.03%)
Sep 22, 2026, 1:31 PM ET · Market open
Fiscal Year
Period Ending
FY 2025
Dec 30, 2025
FY 2024
Dec 30, 2024
FY 2023
Dec 30, 2023
FY 2022
Dec 30, 2022
FY 2021
Dec 30, 2021
FY 2020
Dec 30, 2020
Cash & Equivalents
618.7M 929.03M 477.01M 1.71B 1.54B 1.01B
Short-Term Investments
18.8M 841.97M 756.74M 717.04M 1.26B 1.64B
Long-Term Investments
171.31M 16.39B 15.1B 14.23B 14.63B 13.28B
Other Long-Term Assets
15.97B -15.09B 6.52M 29.63M 4.15M 10M
Receivables
883.7M 26.96M 22.41M 36.6M 68.31M 39.17M
Inventory
n/a n/a n/a n/a n/a n/a
Other Current Assets
-902.2M 4.19M 18.04M 90.52M 6.63M 8.6M
Total Current Assets
619M 1.8B 1.27B 2.55B 2.88B 2.7B
Property-Plant & Equipment
n/a n/a n/a n/a n/a n/a
Goodwill & Intangibles
924.63M 15.13B n/a n/a 5.67M 28.67M
Total Long-Term Assets
17.06B 16.42B 15.11B 14.26B 14.64B 13.32B
Total Assets
19.62B 18.22B 16.38B 16.81B 17.52B 16.02B
Account Payables
19.4M 13.37M 15.17M 7.91M 5.62M 10.78M
Deferred Revenue
n/a n/a n/a n/a n/a n/a
Short-Term Debt
380M 997.77M n/a 997.51M n/a n/a
Other Current Liabilities
163.98M 68.6M 11.38M 12.4M n/a 18.6M
Total Current Liabilities
636.21M 1.25B 161.38M 1.17B 171.25M 307.89M
Long-Term Debt
8.57B 6.61B 6.14B 6.12B 7.1B 5.82B
Other Long-Term Liabilities
682.61M 12.08M 900K 2.5M n/a n/a
Total Long-Term Liabilities
9.27B 6.63B 6.14B 6.12B 7.1B 5.82B
Total Liabilities
9.91B 7.88B 6.3B 7.29B 7.27B 6.12B
Total Debt
8.95B 7.61B 6.14B 7.12B 7.1B 5.82B
Book Value
9.71B 10.34B 10.08B 9.53B 10.25B 9.9B
Book Value Per Share
17.36 17.41 16.73 16.86 24.71 25.50
Common Stock
106K 108K 108K 107K 106K 102K
Retained Earnings
2.36B 2.85B 2.52B 1.96B 2.26B 1.92B
Comprehensive Income
n/a n/a n/a n/a 16.49M 34.4M
Shareholders Equity
6.48B 6.95B 6.53B 5.63B 5.78B 4.82B
Total Investments
190.11M 17.23B 15.86B 14.95B 15.89B 14.93B

© 2026 bestshares.com. All rights reserved.